Nicole Murphy - Dec 2, 2022 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Pharm Ops and Tech
Signature
/s/ Wendell Taylor, attorney in fact for Nicole Murphy
Stock symbol
BIIB
Transactions as of
Dec 2, 2022
Transactions value $
-$11,657
Form type
4
Date filed
12/6/2022, 05:33 PM
Previous filing
Aug 3, 2022
Next filing
Jan 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +131 +4.89% $0.00 2.81K Dec 2, 2022 Direct
transaction BIIB Common Stock Tax liability -$11.7K -39 -1.39% $298.90 2.77K Dec 2, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -131 -100% $0.00* 0 Dec 2, 2022 Common Stock 131 $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award was granted to the reporting person on December 2, 2019 and vested in three equal installments on each anniversary of the grant date.